Skip to main content

Advertisement

Table 3 Changes in cardiovascular risk factors

From: Effectiveness of a motivational intervention on overweight/obese patients in the primary healthcare: a cluster randomized trial

  Usual care Motivational intervention
Baseline1 mean ± SD 1vs4 p-value= 12 months2 mean ± SD 2vs5 p-value= 24 months3 mean ± SD 3vs6 p-value= Baseline4 mean ± SD 12 months5 mean ± SD 24 months6 mean ± SD
Cholesterol 208.5 ± 39.8 0.17 206.4 ± 34.9 0.78 206.7 ± 33.6 0.41 211.5 ± 36.6 207.5 ± 36.4 203.8 ± 36
Triglycerides 135.4 ± (81.6) 0.21 134.7 ± 66.7 0.08 135.4 ± 65.6 0.0001 133.9 ± 93.9 127.6 ± 61.1 125.9 ± 65.1
HDL Cholesterol 54.6 ± 13.1 0.66 53.4 ± 13.5 0.68 54.2 ± 13.7 0.41 55.3 ± 13.4 53.8 ± 11.9 55.4 ± 14.3
LDL Cholesterol 131.6 ± 31.3 0.06 128.4 ± 33.8 0.08 126.4 ± 32.5 0.06 127.6 ± 32.6 125.9 ± 32.5 124.5 ± 35.9
APO A1 1.6 ± 0.3 0.15 1.6 ± 0.4 0.0002 1.5 ± 0.3 0.04 1.6 ± 0.3 1.7 ± 0.3 1.8 ± 0.3
APO B-100 1 ± 0.2 0.10 1 ± 0.2 0.30 0.9 ± 0.2 0.05 1 ± 0.2 0.9 ± 0.2 0.8 ± 0.2
APOB-100/APO-A1 0.62 ± 0.2 0.07 0.62 ± 0.3 0.002 0.55 ± 0.3 0.0003 0.62 ± 0.3 0.52 ± 0.3 0.44 ± 0.3
SBP 130.8 ± 14.8 0.24 129.7 ± 15 0.29 131.7 ± 15.4 0.57 132.6 ± 15.2 130.9 ± 14.1 132.1 ± 14
DBP 78.7 ± 10.3 0.44 78.6 ± 9 0.12 77.0 ± 9.2 0.17 79.3 ± 9.7 78.2 ± 9.1 78.0 ± 8.8
  1. SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure. P-value: Mann-Whitney test
  2. 1UsualCare-Baseline
  3. 2Usual Care-12 months
  4. 3Usual Care-24 months
  5. 4Motivational intervention-Baseline
  6. 5Motivational Intervention-12 months
  7. 6Motivational Intervention-24 months